91,913 Shares in Danaher Corporation $DHR Purchased by Blue Whale Capital LLP

Blue Whale Capital LLP bought a new stake in Danaher Corporation (NYSE:DHRFree Report) during the second quarter, HoldingsChannel.com reports. The fund bought 91,913 shares of the conglomerate’s stock, valued at approximately $17,508,000. Danaher makes up about 0.6% of Blue Whale Capital LLP’s investment portfolio, making the stock its 26th biggest position.

Other institutional investors have also recently bought and sold shares of the company. Main Street Group LTD acquired a new position in Danaher during the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC acquired a new stake in shares of Danaher in the second quarter valued at approximately $25,000. JPL Wealth Management LLC acquired a new stake in shares of Danaher in the third quarter valued at approximately $25,000. WFA of San Diego LLC bought a new stake in shares of Danaher in the second quarter worth $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher in the fourth quarter worth $27,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of analyst reports. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. HSBC reduced their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Citigroup started coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. Evercore reiterated an “outperform” rating and set a $230.00 target price on shares of Danaher in a report on Monday, July 6th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Read Our Latest Analysis on Danaher

Danaher Stock Performance

Shares of DHR stock opened at $219.42 on Monday. The company has a fifty day moving average price of $195.80 and a two-hundred day moving average price of $192.40. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The stock has a market cap of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.77 EPS. As a group, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.